Recently, we showed in infectious disease research that T. cruzi dysregulates the expression profile of host piRNAs computationally predicted to target profibrotic molecules including TGFB1, FOS, and NFATC2 in primary human cardiac myocytes (Rayford et al., 2020). This evidence concerns the gene FOS and infectious disease.